Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


madelon.dejong@kennedy.ox.ac.uk


ORCID ID https://orcid.org/0000-0002-6145-6154


She/her

Social media

Madelon de Jong

MD PhD

Arthritis UK Career Development Fellow

I am an Arthritis UK Career Development Fellow and clinician-scientist at the Kennedy Institute of Rheumatology, where I lead a research programme on bone marrow changes in autoimmune disease.

I trained in Medicine (MD) and Infection & Immunity (MSc) at Erasmus University Rotterdam, and completed my PhD at the Erasmus MC Cancer Institute (with Tom Cupedo and Pieter Sonneveld). During my PhD, I studied the bone marrow microenvironment in multiple myeloma, identifying inflammatory mesenchymal stromal cells (iMSC) with tumour-supportive and myeloid-modulatory properties (de Jong et al., Nature Immunology 2021), and I subsequently showed that stromal cells and neutrophils form a feed-forward inflammatory circuit in diseased bone marrow that persists despite therapy (de Jong et al., Nature Immunology 2024).

Building on this work, my current research focuses on how changes in blood cell production contribute to autoimmune disease, with the aim of identifying new therapeutic opportunities.